Association between fibroblast growth factor 19 and depressive symptoms: the moderating role of smoking
These results highlight the potential role of FGF19 in individuals at risk for presence of or further development of depressive symptoms and underscore the importance of considering smoking status when examining this association.
Authors
- Hongjiao Gao (ORCID: https://orcid.org/0009-0005-1953-3653)
- Yanlong Liu (ORCID: https://orcid.org/0000-0001-8733-8028)
- Yueling Hu
- Weiming Hu (ORCID: https://orcid.org/0000-0001-7870-6968)
- Fan Wang (ORCID: https://orcid.org/0000-0003-3029-1024)
- Siyuan Li (ORCID: https://orcid.org/0009-0003-5648-0760)
- Mingwei Ma
- Xiaokun Li (ORCID: https://orcid.org/0000-0001-8966-4767)
- Xingguang Luο (ORCID: https://orcid.org/0000-0003-3585-042X)
- Wei Wang (ORCID: https://orcid.org/0000-0001-7492-6795)
- Yulin Ren
- Yu-Hsin Chen
- Yimin Kang
- Jing Wu (ORCID: https://orcid.org/0009-0004-6080-5908)
- Ling‐Ling Chen (ORCID: https://orcid.org/0000-0002-3005-526X)
- Li Chen (ORCID: https://orcid.org/0009-0008-4771-2917)
Institutions
- Peking University (CN)
- Wenzhou Medical University (CN)
- Yale University (US)
- Quzhou City People's Hospital (CN)
- Mongolian National University of Medical Sciences (MN)
- Third People's Hospital of Huzhou (CN)
- Beijing HuiLongGuan Hospital (CN)
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- Acta Neuropsychiatrica
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/neu.2025.10028
- Primary Topic
- Fibroblast Growth Factor Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- McKnight Foundation
- University of Cambridge
- Natural Science Foundation of Xinjiang